{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:40:21Z","timestamp":1793814021240,"version":"4.6.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T00:00:00Z","timestamp":1589760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T00:00:00Z","timestamp":1589760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81521001"],"award-info":[{"award-number":["81521001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pathological cardiac hypertrophy eventually leads to heart failure without adequate treatment. REG\u03b3 is emerging as 11S proteasome activator of 20S proteasome to promote the degradation of cellular proteins in a ubiquitin- and ATP-independent manner. Here, we found that REG\u03b3 was significantly upregulated in the transverse aortic constriction (TAC)-induced hypertrophic hearts and angiotensin II (Ang II)-treated cardiomyocytes. REG\u03b3 deficiency ameliorated pressure overload-induced cardiac hypertrophy were associated with inhibition of cardiac reactive oxygen species (ROS) accumulation and suppression of\u00a0protein phosphatase 2A catalytic subunit \u03b1 (PP2Ac\u03b1) decay. Mechanistically, REG\u03b3 interacted with and targeted PP2Ac\u03b1 for degradation directly, thereby leading to increase of phosphorylation levels and nuclear export of Forkhead box protein O (FoxO) 3a and subsequent of SOD2 decline, ROS accumulation, and cardiac hypertrophy. Introducing exogenous PP2Ac\u03b1 or SOD2 to human cardiomyocytes significantly rescued the REG\u03b3-mediated ROS accumulation of Ang II stimulation in vitro. Furthermore, treatment with superoxide dismutase mimetic, MnTBAP prevented cardiac ROS production and hypertrophy features that REG\u03b3 caused in vivo, thereby establishing a REG\u03b3\u2013PP2Ac\u03b1\u2013FoxO3a\u2013SOD2 pathway in cardiac oxidative stress and hypertrophy, indicates modulating the REG\u03b3-proteasome activity may be a potential therapeutic approach in cardiac hypertrophy-associated disorders.<\/jats:p>","DOI":"10.1038\/s41418-020-0554-8","type":"journal-article","created":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T13:08:02Z","timestamp":1589807282000},"page":"2952-2972","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["The proteasome activator REG\u03b3 accelerates cardiac hypertrophy by declining PP2Ac\u03b1\u2013SOD2 pathway"],"prefix":"10.1038","volume":"27","author":[{"given":"Yifan","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rifeng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robb E.","family":"Moses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbo","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,18]]},"reference":[{"key":"554_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1146\/annurev.physiol.65.092101.142243","volume":"65","author":"N Frey","year":"2003","unstructured":"Frey N, Olson EN. Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol. 2003;65:45\u201379.","journal-title":"Annu Rev Physiol"},{"key":"554_CR2","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/j.febslet.2009.12.047","volume":"584","author":"VI Korolchuk","year":"2010","unstructured":"Korolchuk VI, Menzies FM, Rubinsztein DC. Mechanisms of cross-talk between the ubiquitin-proteasome and autophagy-lysosome systems. FEBS Lett. 2010;584:1393\u20138.","journal-title":"FEBS Lett"},{"key":"554_CR3","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.cell.2011.10.026","volume":"147","author":"N Mizushima","year":"2011","unstructured":"Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell 2011;147:728\u201341.","journal-title":"Cell"},{"key":"554_CR4","first-page":"1","volume":"4","author":"F Cacciapuoti","year":"2014","unstructured":"Cacciapuoti F. Role of ubiquitin-proteasome system (UPS) in left ventricular hypertrophy (LVH). Am J Cardiovasc Dis. 2014;4:1\u20135.","journal-title":"Am J Cardiovasc Dis"},{"key":"554_CR5","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.tibs.2005.04.005","volume":"30:","author":"A Varshavsky","year":"2005","unstructured":"Varshavsky A. Regulated protein degradation. Trends Biochem Sci. 2005;30::283\u20136.","journal-title":"Trends Biochem Sci"},{"key":"554_CR6","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S0092-8674(00)81603-7","volume":"94","author":"MH Glickman","year":"1998","unstructured":"Glickman MH, Rubin DM, Coux O, Wefes I, Pfeifer G, Cjeka Z, et al. A subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate degradation and related to the COP9 signalosome and eIF3. Cell. 1998;94:615\u201323.","journal-title":"Cell"},{"key":"554_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.bbamcr.2011.07.009","volume":"1823","author":"S Bar-Nun","year":"2012","unstructured":"Bar-Nun S, Glickman MH. Proteasomal AAA\u2013ATPases: structure and function. Biochim Biophys Acta. 2012;1823:67\u201382.","journal-title":"Biochim Biophys Acta"},{"key":"554_CR8","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1161\/CIRCRESAHA.115.304760","volume":"115","author":"MK Gupta","year":"2014","unstructured":"Gupta MK, Gulick J, Liu R, Wang X, Molkentin JD, Robbins J, et al. Sumo E2 ligase UBC9 is required for efficient protein quality control in cardiomyocytes. Circ Res. 2014;115:721\u20139.","journal-title":"Circ Res."},{"key":"554_CR9","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1161\/CIRCRESAHA.112.300521","volume":"112","author":"J Pagan","year":"2013","unstructured":"Pagan J, Seto T, Pagano M, Cittadini A. Role of the ubiquitin proteasome system in the heart. Circ Res. 2013;112:1046\u201358.","journal-title":"Circ Res."},{"key":"554_CR10","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1093\/eurjhf\/hft034","volume":"15","author":"J Herrmann","year":"2013","unstructured":"Herrmann J, Wohlert C, Saguner AM, Flores A, Nesbitt LL, Chade A, et al. Primary proteasome inhibition results in cardiac dysfunction. Eur J Heart Fail. 2013;15:614\u201323.","journal-title":"Eur J Heart Fail"},{"key":"554_CR11","doi-asserted-by":"crossref","unstructured":"Maejima Y. The critical roles of protein quality control systems in the pathogenesis of heart failure. J Cardiol. 2019;75:219\u201327.","DOI":"10.1016\/j.jjcc.2019.09.019"},{"key":"554_CR12","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cell.2005.11.037","volume":"124","author":"X Li","year":"2006","unstructured":"Li X, Lonard DM, Jung SY, Malovannaya A, Feng Q, Qin J, et al. The SRC-3\/AIB1 coactivator is degraded in a ubiquitin- and ATP-independent manner by the REG\u03b3 proteasome. Cell. 2006;124:381\u201392.","journal-title":"Cell."},{"key":"554_CR13","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.molcel.2007.05.022","volume":"26","author":"X Chen","year":"2007","unstructured":"Chen X, Barton LF, Chi Y, Clurman BE, Roberts JM. Ubiquitin-independent degradation of cell-cycle inhibitors by the REG\u03b3 proteasome. Mol Cell. 2007;26:843\u201352.","journal-title":"Mol Cell."},{"key":"554_CR14","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.molcel.2007.05.028","volume":"26","author":"X Li","year":"2007","unstructured":"Li X, Amazit L, Long W, Lonard DM, Monaco JJ, O\u2019Malley BW. Ubiquitin- and ATP-independent proteolytic turnover of p21 by the REG\u03b3amma-proteasome pathway. Mol Cell. 2007;26:831\u201342.","journal-title":"Mol Cell."},{"key":"554_CR15","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1007\/s00018-008-8291-z","volume":"65","author":"I Mao","year":"2008","unstructured":"Mao I, Liu J, Li X, Luo H. REG\u03b3, a proteasome activator and beyond? Cell Mol Life Sci. 2008;65:3971\u201380.","journal-title":"Cell Mol Life Sci"},{"key":"554_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3667","volume":"4","author":"A Amjad","year":"2013","unstructured":"Amjad A, Wang Z, Fu J, Ji L, Liu J, Li L, et al. Differential regulation of the REG\u03b3-proteasome pathway by p53\/TGF-b signalling and mutant p53 in cancer cells. Nat Commun. 2013;4:2667.","journal-title":"Nat Commun."},{"key":"554_CR17","doi-asserted-by":"publisher","first-page":"4076","DOI":"10.1242\/jcs.067405","volume":"123","author":"J Liu","year":"2010","unstructured":"Liu J, Yu G, Zhao Y, Zha D, Wang Y, Wang L, et al. REG\u03b3 modulates p53 activity by regulating its cellularlocalization. J Cell Sci. 2010;123:4076\u201384.","journal-title":"J Cell Sci"},{"key":"554_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7875","volume":"2","author":"L Li","year":"2015","unstructured":"Li L, Dang Y, Zhang J, Yan W, Zhai W, Chen H, et al. TETREG\u03b3 is critical for skin carcinogenesis by modulating the Wnt\/\u03b2-catenin pathway. Nat Commun. 2015;2:6875.","journal-title":"Nat Commun."},{"key":"554_CR19","doi-asserted-by":"publisher","unstructured":"Jiao C, Li L, Zhang P, Zhang L, Li K, Fang R, et al. REG\u03b3 ablation impedes dedifferentiation of anaplastic thyroid carcinoma and accentuates radio-therapeutic response by regulating the Smad7-TGF-\u03b2 pathway. Cell Death Differ. 2019. https:\/\/doi.org\/10.1038\/s41418-019-0367-9.","DOI":"10.1038\/s41418-019-0367-9"},{"key":"554_CR20","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1038\/cdd.2014.188","volume":"22","author":"S Li","year":"2015","unstructured":"Li S, Jiang C, Pan J, Wang X, Jin J, Zhao L, et al. Cell death & regulation of c-Myc protein stability by proteasome activator REG\u03b3. Cell Death Differ. 2015;22:1000\u201311.","journal-title":"Cell Death Differ"},{"key":"554_CR21","doi-asserted-by":"publisher","first-page":"11005","DOI":"10.1073\/pnas.1308497110","volume":"110","author":"L Li","year":"2013","unstructured":"Li L, Zhao D, Wei H, Yao L, Dang Y, Amjad A, et al. REG\u03b3 deficiency promotes premature aging via the casein kinase 1 pathway. Proc Natl Acad Sci USA. 2013;110:11005\u201310.","journal-title":"Proc Natl Acad Sci USA"},{"key":"554_CR22","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.cmet.2013.08.012","volume":"18","author":"S Dong","year":"2013","unstructured":"Dong S, Jia C, Zhang S, Fan G, Li Y, Shan P, et al. The REG\u03b3 proteasome regulates hepatic lipid metabolism through inhibition of autophagy. Cell Metab. 2013;18:380\u201391.","journal-title":"Cell Metab."},{"key":"554_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12497","volume":"7","author":"L Sun","year":"2016","unstructured":"Sun L, Fan G, Shan P, Qiu X, Dong S, Liao L, et al. Regulation of energy homeostasis by the ubiquitin-independent REG\u03b3 proteasome. Nat Commun. 2016;7:12497.","journal-title":"Nat Commun."},{"key":"554_CR24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.yjmcc.2014.02.007","volume":"72","author":"S Liu","year":"2014","unstructured":"Liu S, Lai L, Zuo Q, Dai F, Wu L, Wang Y, et al. PKA turnover by the REG\u03b3-proteasome modulates FoxO1 cellular activity and VEGF-induced angiogenesis. J Mol Cell Cardiol. 2014;72:28\u201338.","journal-title":"J Mol Cell Cardiol"},{"key":"554_CR25","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1080\/15384101.2019.1639304","volume":"18","author":"Y Xie","year":"2019","unstructured":"Xie Y, Li X, Ge J. Expression of REG\u03b3 in atherosclerotic plaques and promotes endothelial cells apoptosis via the cyclophilin A pathway indicates functional implications in atherogenesis. Cell Cycle. 2019;18:2083\u201398.","journal-title":"Cell Cycle."},{"key":"554_CR26","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.freeradbiomed.2015.01.024","volume":"82","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Liu S, Zuo Q, Wu L, Ji L, Zhai W, et al. Oxidative challenge enhances REG\u03b3-proteasome-dependent protein degradation. Free Radic Biol Med. 2015;82:42\u20139.","journal-title":"Free Radic Biol Med"},{"key":"554_CR27","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.celrep.2015.12.069","volume":"14","author":"J Sun","year":"2016","unstructured":"Sun J, Luan Y, Xiang D, Tan X, Chen H, Deng Q, et al. The 11S proteasome subunit PSME3 is a positive feedforward regulator of NF-\u03baB and important for host defense against bacterial pathogens. Cell Rep. 2016;14:737\u201349.","journal-title":"Cell Rep."},{"key":"554_CR28","doi-asserted-by":"publisher","unstructured":"Zhou L, Yao L, Zhang Q, Xie W, Wang X, Zhang H, et al. REG\u03b3 controls Th17 cell differentiation and autoimmune inflammation by regulating dendritic cells. Cell Mol Immunol. 2019. https:\/\/doi.org\/10.1038\/s41423-019-0287-0.","DOI":"10.1038\/s41423-019-0287-0"},{"key":"554_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10761","volume":"7","author":"J Xu","year":"2016","unstructured":"Xu J, Zhou L, Ji L, Chen F, Fortmann K, Zhang K, et al. The REG\u03b3-proteasome forms a regulatory circuit with IkBe and NF-kB in experimental colitis. Nat Commun. 2016;7:10761.","journal-title":"Nat Commun."},{"key":"554_CR30","doi-asserted-by":"publisher","first-page":"3948","DOI":"10.4049\/jimmunol.172.6.3948","volume":"172","author":"LF Barton","year":"2004","unstructured":"Barton LF, Runnels HA, Schell TD, Cho Y, Gibbons R, Tevethia SS, et al. Immune defects in 28-kDa proteasome activator gamma-deficient mice. J Immunol. 2004;172:3948\u201354.","journal-title":"J Immunol."},{"key":"554_CR31","doi-asserted-by":"publisher","first-page":"11056","DOI":"10.1128\/JVI.00008-10","volume":"84","author":"G Gao","year":"2010","unstructured":"Gao G, Wong J, Zhang J, Mao I, Shravah J, Wu Y, et al. Proteasome activator REG\u03b3 enhances coxsackieviral infection by facilitating p53 degradation. J Virol. 2010;84:11056\u201366.","journal-title":"J Virol"},{"key":"554_CR32","doi-asserted-by":"publisher","first-page":"37455","DOI":"10.1074\/jbc.274.52.37455","volume":"274","author":"HP Kim","year":"1999","unstructured":"Kim HP, Roe JH, Chock PB, Yim MB. Transcriptional activation of the human manganese superoxide dismutase gene mediated by tetradecanoylphorbol acetate. J Biol Chem. 1999;274:37455\u201360.","journal-title":"J Biol Chem"},{"key":"554_CR33","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/cvr\/cvp344","volume":"85","author":"H Bugger","year":"2010","unstructured":"Bugger H, Schwarzer D, Chen A, Schrepper PA, Amorim M, Schoepe TD, et al. Proteomic remodelling of mitochondrial oxidative pathways in pressure overload-induced heart failure. Cardiovasc Res. 2010;85:376\u201384.","journal-title":"Cardiovasc Res"},{"key":"554_CR34","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1093\/eurheartj\/ehv305","volume":"36","author":"T Munzel","year":"2015","unstructured":"Munzel T, Gori T, Keaney JF Jr, Maack C, Daiber A. Pathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implications. Eur Heart J. 2015;36:2555\u201364.","journal-title":"Eur Heart J"},{"key":"554_CR35","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1161\/CIRCRESAHA.110.232306","volume":"108","author":"DF Dai","year":"2011","unstructured":"Dai DF, Johnson SC, Villarin JJ, Chin MT, Nieves-Cintron M, Chen T, et al. Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure. Circ Res. 2011;108:837\u201346.","journal-title":"Circ Res."},{"key":"554_CR36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.yjmcc.2015.04.012","volume":"84","author":"H Wang","year":"2015","unstructured":"Wang H, Lai Y, Mathis BJ, Wang W, Li S, Qu C, et al. Deubiquitinating enzyme CYLD mediates pressure overload-induced cardiac maladaptive remodeling and dysfunction via downregulating Nrf2. J Mol Cell Cardiol. 2015;84:143\u201353.","journal-title":"J Mol Cell Cardiol"},{"key":"554_CR37","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/cvr\/cvx204","volume":"114","author":"M Zhang","year":"2018","unstructured":"Zhang M, Mongue-Din H, Martin D, Catibog N, Smyrnias I, Zhang X, et al. Both cardiomyocyte and endothelial cell Nox4 mediate protection against hemodynamic overload-induced remodelling. Cardiovasc Res. 2018;114:401\u20138.","journal-title":"Cardiovasc Res"},{"key":"554_CR38","doi-asserted-by":"publisher","first-page":"12525","DOI":"10.1074\/jbc.RA118.003471","volume":"93","author":"JA Martina","year":"2018","unstructured":"Martina JA, Puertollano R. Protein phosphatase 2A stimulates activation of TFEB and TFE3 transcription factors in response to oxidative stress. J Biol Chem. 2018;93:12525\u201334.","journal-title":"J Biol Chem"},{"key":"554_CR39","first-page":"1769","volume":"8","author":"L Li","year":"2016","unstructured":"Li L, Fang C, Xu D, Xu Y, Fu H, Li J. Cardiomyocyte specific deletion of PP2A causes cardiac hypertrophy. Am J Transl Res. 2016;8:1769\u201379.","journal-title":"Am J Transl Res"},{"key":"554_CR40","volume":"50","author":"S Yoon","year":"2018","unstructured":"Yoon S, Kook T, Min HK, Kwon DH, Cho YK, Kim M, et al. PP2A negatively regulates the hypertrophic response by dephosphorylating HDAC2 S394 in the heart. Exp Mol Med. 2018;50:83.","journal-title":"Exp Mol Med"},{"key":"554_CR41","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1042\/bj3530417","volume":"353","author":"V Janssens","year":"2001","unstructured":"Janssens V, Goris J. Protein phosphatase 2A: a highly regulated family of serine\/threonine phosphatases implicated in cell growth and signalling. Biochem J. 2001;353:417\u201339.","journal-title":"Biochem J"},{"key":"554_CR42","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0955-0674(99)00074-5","volume":"12","author":"DM Virshup","year":"2000","unstructured":"Virshup DM. Protein phosphatase 2A: a panoply of enzymes. Curr Opin Cell Biol. 2000;12:180\u20135.","journal-title":"Curr Opin Cell Biol"},{"key":"554_CR43","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00395-017-0625-2","volume":"112","author":"O Eleftheriadou","year":"2017","unstructured":"Eleftheriadou O, Boguslavskyi A, Longman MR, Cowan J, Francois A, Heads RJ, et al. Expression and regulation of type 2A protein phosphatases and alpha4 signalling in cardiac health and hypertrophy. Basic Res Cardiol. 2017;112:37.","journal-title":"Basic Res Cardiol"},{"key":"554_CR44","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1096\/fj.201500194R","volume":"30","author":"M Guillonneau","year":"2016","unstructured":"Guillonneau M, Paris F, Dutoit S, Estephan H, B\u00e9n\u00e9teau E, Huot J, et al. Oxidative stress disassembles the p38\/NPM\/PP2A complex, which leads to modulation of nucleophosmin-mediated signaling to DNA damage response. FASEB J. 2016;30:2899\u2013914.","journal-title":"FASEB J."},{"key":"554_CR45","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.yjmcc.2019.04.011","volume":"130","author":"GF Zuo","year":"2019","unstructured":"Zuo GF, Ren XM, Ge Q, Luo J, Ye P, Wang F, et al. Activation of the PP2A catalytic subunit by ivabradine attenuates the development of diabetic cardiomyopathy. J Mol Cell Cardiol. 2019;130:170\u201383.","journal-title":"J Mol Cell Cardiol"},{"key":"554_CR46","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1111\/bph.14648","volume":"176","author":"IS Elgenaidi","year":"2019","unstructured":"Elgenaidi IS, Spiers JP. Hypoxia modulates protein phosphatase 2A through HIF-1\u03b1 dependent and independent mechanisms in human aortic smooth muscle cells and ventricular cardiomyocytes. Br J Pharm. 2019;176:1745\u201363.","journal-title":"Br J Pharm"},{"key":"554_CR47","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1161\/CIRCRESAHA.118.314350","volume":"124","author":"M El Refaey","year":"2019","unstructured":"El Refaey M, Musa H, Murphy NP, Lubbers ER, Skaf M, Han M, et al. Protein phosphatase 2A regulates cardiac Na+ channels. Circ Res. 2019;124:737\u201346.","journal-title":"Circ Res."},{"key":"554_CR48","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.yjmcc.2016.11.003","volume":"101","author":"ER Lubbers","year":"2016","unstructured":"Lubbers ER, Mohler PJ. Roles and regulation of protein phosphatase 2A (PP2A) in the heart. J Mol Cell Cardiol. 2016;101:127\u201333.","journal-title":"J Mol Cell Cardiol"},{"key":"554_CR49","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/cvr\/cvy230","volume":"115","author":"SL Puhl","year":"2019","unstructured":"Puhl SL, Weeks KL, G\u00fcran A, Ranieri A, Boknik P, Kirchhefer U, et al. Role of type 2A phosphatase regulatory subunit B56\u03b1 in regulating cardiac responses to \u03b2-adrenergic stimulation in vivo. Cardiovasc Res. 2019;115:519\u201329.","journal-title":"Cardiovasc Res"},{"key":"554_CR50","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1161\/CIRCULATIONAHA.114.012725","volume":"131","author":"QH Huang","year":"2015","unstructured":"Huang QH, Zhou HJ, Zhang HF, Huang Y, Hinojosa-Kirschenbaum F, Fan PD, et al. Thioredoxin-2 inhibits mitochondrial reactive oxygen species generation and apoptosis stress kinase-1 activity to maintain cardiac function. Circulation. 2015;131:1082\u201397.","journal-title":"Circulation."},{"key":"554_CR51","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1093\/cvr\/cvp092","volume":"82","author":"T Loch","year":"2009","unstructured":"Loch T, Vakhrusheva O, Piotrowska I, Ziolkowski W, Ebelt H, Braun T, et al. Different extent of cardiac malfunction and resistance to oxidative stress in heterozygous and homozygous manganese-dependent superoxide dismutase-mutant mice. Cardiovasc Res. 2009;82:448\u201357.","journal-title":"Cardiovasc Res"},{"key":"554_CR52","doi-asserted-by":"publisher","first-page":"33789","DOI":"10.1074\/jbc.M602118200","volume":"281","author":"H Nojiri","year":"2006","unstructured":"Nojiri H, Shimizu T, Funakoshi M, Yamaguchi O, Zhou H, Kawakami S, et al. Oxidative stress causes heart failure with impaired mitochondrial respiration. J Biol Chem. 2006;281:33789\u2013801.","journal-title":"J Biol Chem"},{"key":"554_CR53","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1161\/01.CIR.0000109701.77059.E9","volume":"109","author":"T Shiomi","year":"2004","unstructured":"Shiomi T, Tsutsui H, Matsusaka H, Murakami K, Hayashidani S, Ikeuchi M, et al. Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice. Circulation. 2004;109:544\u20139.","journal-title":"Circulation."},{"key":"554_CR54","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1093\/eurheartj\/ehx493.P6486","volume":"38","author":"YX Luo","year":"2017","unstructured":"Luo YX, Tang X, An XZ, Xie XM, Chen XF, Zhao X, et al. SIRT4 accelerates Ang II-induced pathological cardiac hypertrophy by inhibiting manganese superoxide dismutase activity. Eur Heart J. 2017;38:1389\u201398.","journal-title":"Eur Heart J"},{"key":"554_CR55","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/nature01036","volume":"419","author":"GJ Kops","year":"2002","unstructured":"Kops GJ, Dansen TB, Polderman PE, Saarloos I, Wirtz KW, Coffer PJ, et al. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature. 2002;419:316\u201321.","journal-title":"Nature."},{"key":"554_CR56","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/cdd.2011.179","volume":"19","author":"EC Ferber","year":"2012","unstructured":"Ferber EC, Peck B, Delpuech O, Bell GP, East P, Schulze A. FOXO3a regulates reactive oxygen metabolism by inhibiting mitochondrial gene expression. Cell Death Differ. 2012;19:968\u201379.","journal-title":"Cell Death Differ"},{"key":"554_CR57","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1042\/bj20040167","volume":"380","author":"LP Van Der Heide","year":"2004","unstructured":"Van Der Heide LP, Hoekman MF, Smidt MP. The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation. Biochem J. 2004;380:297\u2013309.","journal-title":"Biochem J"},{"key":"554_CR58","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1523\/JNEUROSCI.5103-05.2006","volume":"26","author":"KJ Yin","year":"2006","unstructured":"Yin KJ, Hsu CY, Hu XY, Chen H, Chen SW, Xu J, et al. Protein phosphatase 2A regulates bim expression via the Akt\/FKHRL1 signaling pathway in amyloid-\u03b2 peptide-induced cerebrovascular endothelial cell death. J Neurosci. 2006;26:2290\u20139.","journal-title":"J Neurosci"},{"key":"554_CR59","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S0092-8674(00)80595-4","volume":"96","author":"A Brunet","year":"1999","unstructured":"Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu L, et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell. 1999;96:857\u201368.","journal-title":"Cell."},{"key":"554_CR60","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1128\/MCB.21.3.952-965.2001","volume":"21","author":"A Brunet","year":"2001","unstructured":"Brunet A, Park J, Tran H, Hu LS, Hemmings BA, Greenberg ME. Protein kinase SGK mediates survival signals by phosphorylating the Forkhead transcription factor FKHRL1 (FOXO3a). Mol Cell Biol. 2001;21:952\u201365.","journal-title":"Mol Cell Biol"},{"key":"554_CR61","doi-asserted-by":"publisher","first-page":"27141","DOI":"10.1074\/jbc.M704391200","volume":"282","author":"FJ Barreyro","year":"2007","unstructured":"Barreyro FJ, Kobayashi S, Bronk SF, Werneburg NW, Malhi H, Gores GJ. Transcriptional regulation of bim by FoxO3A mediates hepatocyte lipoapoptosis. J Biol Chem. 2007;282:27141\u201354.","journal-title":"J Biol Chem"},{"key":"554_CR62","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1091\/mbc.e09-09-0795","volume":"21","author":"A Singh","year":"2010","unstructured":"Singh A, Ye M, Bucur O, Zhu S, Tanya Santos M, Rabinovitz I, et al. Protein phosphatase 2A reactivates FOXO3a through a dynamic interplay with 14-3-3 and AKT. Mol Biol Cell. 2010;21:1140\u201352.","journal-title":"Mol Biol Cell"},{"key":"554_CR63","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/onc.2008.425","volume":"28","author":"C Bertoli","year":"2009","unstructured":"Bertoli C, Copetti T, Lam EW, Demarchi F, Schneider C. Calpain small-1 modulates Akt\/FoxO3A signaling and apoptosis through PP2A. Oncogene. 2009;28:721\u201333.","journal-title":"Oncogene"},{"key":"554_CR64","doi-asserted-by":"publisher","first-page":"14195","DOI":"10.1074\/jbc.M109.052845","volume":"285","author":"RS Nho","year":"2010","unstructured":"Nho RS, Kahm J. \u03b21-integrin-collagen interaction suppresses FoxO3a by the coordination of Akt and PP2A. J Biol Chem. 2010;285:14195\u2013209.","journal-title":"J Biol Chem"},{"key":"554_CR65","doi-asserted-by":"publisher","first-page":"9782","DOI":"10.1073\/pnas.93.18.9782","volume":"93","author":"RM Lebovitz","year":"1996","unstructured":"Lebovitz RM, Zhang H, Vogel H, Cartwright J Jr, Dionne L, Lu N, et al. Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc Natl Acad Sci USA. 1996;93:9782\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"554_CR66","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1161\/CIRCRESAHA.111.246140","volume":"110","author":"DF Dai","year":"2012","unstructured":"Dai DF, Rabinovitch PS, Ungvari Z. Mitochondria and cardiovascular aging. Circ Res. 2012;110:1109\u201324.","journal-title":"Circ Res."},{"key":"554_CR67","doi-asserted-by":"publisher","first-page":"3258","DOI":"10.1093\/eurheartj\/ehu436","volume":"35","author":"A Eirin","year":"2014","unstructured":"Eirin A, Lerman A, Lerman LO. Mitochondrial injury and dysfunction in hypertension-induced cardiac damage. Eur Heart J. 2014;35:3258\u201366.","journal-title":"Eur Heart J"},{"key":"554_CR68","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1006\/bbrc.1999.1036","volume":"261","author":"S Hiroi","year":"1999","unstructured":"Hiroi S, Harada H, Nishi H, Satoh M, Nagai R, Kimura A. Polymorphisms in the SOD2 and HLA-DRB1 genes are associated with nonfamilial idiopathic dilated cardiomyopathy in Japanese. Biochem Biophys Res Commun. 1999;261:332\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"554_CR69","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1155\/2006\/983408","volume":"22","author":"KG Dos Santos","year":"2006","unstructured":"Dos Santos KG, Canani LH, Gross JL, Tschiedel B, Souto KE, Roisenberg I. The catalase-262C\/T promoter polymorphism and diabetic complications in Caucasians with type 2 diabetes. Dis Markers. 2006;22:355\u20139.","journal-title":"Dis Markers."},{"key":"554_CR70","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1093\/eurheartj\/ehq507","volume":"32","author":"D Sibbing","year":"2011","unstructured":"Sibbing D, Pfeufer A, Perisic T, Mannes AM, Fritz-Wolf K, Unwin S, et al. Mutations in the mitochondrial thioredoxin reductase gene TXNRD2 cause dilated cardiomyopathy. Eur Heart J. 2011;32:1121\u201333.","journal-title":"Eur Heart J"},{"key":"554_CR71","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.2337\/diabetes.53.9.2455","volume":"53","author":"T Hamanishi","year":"2004","unstructured":"Hamanishi T, Furuta H, Kato H, Doi A, Tamai M, Shimomura H, et al. Functional variants in the glutathione peroxidase-1 (GPx-1) gene are associated with increased intima-media thickness of carotid arteries and risk of macrovascular diseases in Japanese type 2 diabetic patients. Diabetes. 2004;53:2455\u201360.","journal-title":"Diabetes."},{"key":"554_CR72","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/ng1295-376","volume":"11","author":"Y Li","year":"1995","unstructured":"Li Y, Huang TT, Carlson EJ, Melov S, Ursell PC, Olson JL, et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet. 1995;11:376\u201381.","journal-title":"Nat Genet."},{"key":"554_CR73","first-page":"2758","volume":"119","author":"NR Sundaresan","year":"2009","unstructured":"Sundaresan NR, Gupta M, Kim G, Rajamohan SB, Isbatan A, Gupta MP. Sirt3 blocks the ardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J Clin Investig. 2009;119:2758\u201371.","journal-title":"J Clin Investig"},{"key":"554_CR74","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.cardfail.2005.01.007","volume":"11","author":"F Sam","year":"2005","unstructured":"Sam F, Kerstetter DL, Pimental DR, Mulukutla S, Tabaee A, Bristow MR, et al. Increased reactive oxygen species production and functional alterations in antioxidant enzymes in human failing myocardium. J Card Fail. 2005;11:473\u201380.","journal-title":"J Card Fail"},{"key":"554_CR75","doi-asserted-by":"publisher","first-page":"20517","DOI":"10.1073\/pnas.0610290104","volume":"104","author":"Y Ni","year":"2007","unstructured":"Ni Y, Wang N, Cao D, Sachan N, Morris D, Gerard R, et al. FoxO transcription factors activate Akt and attenuate insulin signaling in heart by inhibiting protein phosphatases. Proc Natl Acad Sci USA. 2007;104:20517\u201322.","journal-title":"Proc Natl Acad Sci USA."}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-020-0554-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-020-0554-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-020-0554-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T08:08:33Z","timestamp":1650528513000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-020-0554-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,18]]},"references-count":75,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["554"],"URL":"https:\/\/doi.org\/10.1038\/s41418-020-0554-8","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,18]]},"assertion":[{"value":"20 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}